Choroidal Thickness Vitrectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

76 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-16

Study Completion Date

2018-03-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the influence of vitrectomy on changes in central choroidea and comparing the results in imaging of the choroidea with two different OCT devices.

This is a prospective, open, non-randomized, observational, MPG study This study will be performed at the Department of Ophthalmology, Medical University of Vienna.

40 Patients who undergo vitrectomy will be included into this study. The investigation will help to gain new information about the effects of vitrectomy on the choroid.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling

NCT04472039

Macular Edema, Cystoid

COMPLETED

"Cataract Surgery in Eyes With Epiretinal Membrane"

NCT03404323

Epiretinal Membrane Pseudophakic Cystoid Macular Edema Irvine-Gass Syndrome +1 more

COMPLETED

Instrument Tissue Interaction at the Grasp Site During Membrane Peeling of Epiretinal Membranes

NCT06459284

Epiretinal Membrane

COMPLETED

EFFECTIVENESS AND SAFETY ASSESSMENT OF THE VISTA VITRECTOMY PROBE

NCT07140692

Vitreous Floaters Vitreous Opacities

COMPLETED NA

Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes

NCT01771939

Epiretinal Membrane

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Since the development of new OCT modalities, like enhanced depth or swept-source OCT imaging, a better visualization and evaluation of retinal structures and the choroidea became possible. 23G Vitrectomy and membrane peeling seem to have an influence on posterior segment structures of the eye but data show no clear evidence evaluating those changes after surgery. Only little information is currently available on the influence or the changes resulting from vitreous surgery on the central choroidea. Hence, the aim of this study is to evaluate those influences resulting on choroidea using two different OCT devices.

To assess the influence of vitrectomy on changes in central choroidea and comparing the results in imaging of the choroidea with two different OCT devices.

This is a prospective, open, non-randomized, observational, MPG study This study will be performed at the Department of Ophthalmology, Medical University of Vienna.

40 Patients who undergo vitrectomy will be included into this study. The investigation will help to gain new information about the effects of vitrectomy on the choroid.

The measuring procedures used in this study are well tolerated and used in routine clinical practice and are non-invasive.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epiretinal Membrane

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with epiretinal membrane scheduled to undergo vitrectomy without endotamponade
* Male or female, at least 18 years of age
* Written informed consent has been obtained
* Visual acuity ≥0.4

Exclusion Criteria

* Any abnormalities preventing reliable measurements as judged by the investigator
* Participation in a clinical trial in the 3 weeks preceding the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No